ECOG-ACRIN Cancer Research Group
@eaonc
Followers
6K
Following
3K
Media
4K
Statuses
8K
Biomarker-driven medical research involving adults who have or are at risk of developing cancer
1400+ member research sites
Joined November 2013
Read more from our co-chairs on the importance of protecting public support for biomedical research: #CancerResearch #ClinicalTrials
1
8
23
RT @jordanberlin5: Great piece on the importance of maintaining, not cutting, federal funding of research. Millions of people have benefit….
0
2
0
RT @PGrivasMDPhD: Thanks @eaonc for highlighting the important mission to serve patients via innovative transformative research! Supporting….
0
6
0
#ClinicalTrial EA4231, led by @MelanicjMD of @theNCI, is testing the effectiveness of a combination #TargetedTherapy for patients with aggressive B-cell #Lymphoma that has recurred or is resistant to treatment. For more info: cc: @LLSusa, @lymphomahub
0
0
1
#Clinicaltrial EA8192 aims to find out if treatment with durvalumab and chemotherapy can improve outcomes for patients with high grade upper tract #urothelialcancer prior to nephroureterectomy. #blcsm #bladdercancer cc: @JCensits, @PGrivasMDPhD
0
1
2
Do you have advanced #cancer that has become worse following treatment, or advanced cancer for which no standard treatment exists? If so, you may be able to join the #ComboMATCH #PrecisionMedicine study. Learn more:
0
0
0
RT @DrYukselUrun: Every unfinished trial means a lost chance for patients. Let’s keep moving, for the promise, for the people.
0
2
0
RT @FlavioRochaMD: Support #clinicaltrials #cancerresearch 🔬 🧐 .This is how we move the 🪡 to help #endcancer.
0
3
0
RT @BalazsHalmosMD: Stop!. Please stop everything you are doing right now and read below super-important message from ECOG-ACRIN chairs- Dr….
0
7
0
#ComboMATCH Treatment Trial E5, led by @kspencer725 of @Perlmutter_CC and @DocDustyD of @UWCarbone, is a randomized phase 2 study of #sotorasib with or without #panitumumab in advanced #SolidTumors. Learn more here: #PrecisionMedicine
0
1
4
Can patients with high-risk retroperitoneal #sarcoma benefit from neoadjuvant chemotherapy? The international EA7211/STRASS 2 #ClinicalTrial, led in the US by @kencardonaMD, aims to find out. More: #leiomyosarcoma #liposarcoma Cc: @EORTC @richardriedelmd
0
1
2
Could biomarkers on PET/CT imaging propel early discontinuation of anti-PD-1 therapy in patients with unresectable stage IIIB-IV #Melanoma? #ClinicalTrial EA6192/PET-Stop aims to find out. Learn more:
0
0
1
The EAA173/DETER-SMM #ClinicalTrial is exploring new treatments for patients with high-risk #SmolderingMyeloma. Interested in learning more? Click here: cc: @nsc_natalie, @mtmdphd, @VincentRK, @NorthTxMSG
0
3
1
Do you have #AcuteMyeloidLeukemia (#AML) and are age 60 or older? If so, you may be able to participate in this study of a potential new treatment. Learn more: #leukemia #leusm
0
0
0
Do you have newly diagnosed #Glioblastoma? If so, you may be able to participate in this study of a new treatment approach. Learn more about EAF223/GABLE here:
0
0
0
#ClinicalTrial EA5221/ACHIEVE, led by Dr. Megan Baumgart of @URMC_DeptMed & @WilmotCancer, aims to help older patients with #LungCancer live longer while also maintaining a good quality of life. Learn more: #NSCLC #LCSM
0
0
1
.@michael_lidsky of @DukeSurgOnc and @DukeCancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: cc : @CCAlliance, @LiverUSA
0
2
8